Cozart clinches UK Home Office deal for confirmation DOA testing:
This article was originally published in Clinica
Diagnostics developer Cozart has won a contract with the UK Home Office for laboratory oral fluid drug confirmation testing, a deal that could boost the company's top-line by £700,000 ($1.4m) in the first year. The initial one-year, sole-supplier contract is based on a four-year framework agreement between the Abingdon, Oxfordshire-based company and the Home Office. Under the terms of the deal, Cozart will perform follow-up lab confirmation tests - if and when required - for cocaine and heroin after the samples have already been screened (using Cozart's RapiScan test) in police custody suites as part of a national drug interventions programme.